Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02805517 · ClinicalTrials.gov registry record · NA
Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02805517 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 6 participants.
The verdict
NCT02805517, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
A single-arm prospective internally-controlled study. Patients will undergo Percutaneous Externally-Assembled Laparoscopic (PEAL) donor nephrectomy where one or more 3 mm instruments are added or substituted for conventional 5 or 12 mm trocars. Multiple outcome measures (endpoints) will be measured including time to first opioid use, total inpatient opioid dosage, patient ranking of painfulness of each port site, duration of ileus, time to ambulation, length of hospital stay, presence of any intraoperative or postoperative complications, operating time, estimated blood loss, and other routine parameters collected in a prospective surgical study
Interventions
- DEVICE Percuvance™ Percutaneous Surgical System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-07-11 |
| Est. Completion | 2021-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02805517
The ClinicalTrials.gov registry entry for NCT02805517 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percuvance™ Percutaneous Surgical System is the first listed.
NCT02805517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02805517 about?
NCT02805517 is a clinical study titled "Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy". A single-arm prospective internally-controlled study. Patients will undergo Percutaneous Externally-Assembled Laparoscopic (PEAL) donor nephrectomy where one or more 3 mm instruments are added or substituted for conventional 5 or 12 mm trocars. Multiple outcome measures (endpoints) will be measured ...
What is the current status of trial NCT02805517?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-07-11. Estimated completion is 2021-05-26.
What interventions are being tested in trial NCT02805517?
The interventions under investigation include: Percuvance™ Percutaneous Surgical System (DEVICE).
Who is sponsoring clinical trial NCT02805517?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.